A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : SARS-CoV-2

Search Conditions:
Search Keyword : SARS-CoV-2
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: SARS-CoV-2
Appearance Frequency: 4818 time(s)
Long forms: 34

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
severe acute respiratory syndrome coronavirus 2
(4486 times)
Medicine
(421 times)
COVID-19 (2318 times)
ACE2 (273 times)
RT-PCR (175 times)
2020 Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China.
syndrome coronavirus 2
(218 times)
Medicine
(26 times)
COVID-19 (107 times)
ACE2 (13 times)
ARDS (10 times)
2020 Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.
SARS coronavirus 2
(59 times)
Medicine
(7 times)
COVID-19 (25 times)
SARS (11 times)
ACE2 (8 times)
2020 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Since December 2019, novel coronavirus
(7 times)
Communicable Diseases
(2 times)
AST (1 time)
AUC (1 time)
BMI (1 time)
2020 Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.
Sequence of a 2019 Novel Coronavirus
(6 times)
Microbiological Phenomena
(4 times)
COVID-19 (3 times)
2020 Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal.
syndrome associated coronavirus 2
(6 times)
Cardiology
(1 time)
COVID-19 (3 times)
CT (1 time)
IAP (1 time)
2020 Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19.
syndrome coronavirus clade 2
(4 times)
Cell Biology
(1 time)
COVID-19 (2 times)
ACE2 (1 time)
ISG (1 time)
2020 SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
Syndrome Corona Virus-2
(3 times)
Virology
(1 time)
COVID (1 time)
LMWH (1 time)
VTE (1 time)
2020 Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19.
severe acute respiratory infections caused by 2019 novel coronavirus
(2 times)
--- 2020 Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2).
10  syndrome coronavirus 2 virus
(2 times)
Nephrology
(1 time)
COVID-19 (2 times)
2020 COVID-19 Pneumonia in a Hemodialysis Patient.
11  syndrome novel coronavirus 2
(2 times)
Emergency Medicine
(1 time)
3CLpro (1 time)
COVID-19 (1 time)
2020 Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro).
12  schwere akute respiratorische Syndrom-Coronavirus2
(1 time)
Dermatology
(1 time)
--- 2020 
13  serious respiratory condition created by the coronavirus 2
(1 time)
--- 2020 Credible Protein Targets and Curative Strategies for COVID-19: a Review.
14  serological test in the diagnosis of 2019 novel coronavirus
(1 time)
Communicable Diseases
(1 time)
SARS-CoV (1 time)
2020 Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
15  severe acute coronavirus 2
(1 time)
Pediatrics
(1 time)
COVID-19 (1 time)
2020 Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain.
16  severe acute respiratory illness caused by the coronavirus 2
(1 time)
Aging
(1 time)
ASCs (1 time)
COVID-19 (1 time)
MSCs (1 time)
2020 Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease.
17  Severe Acute Syndrome Coronavirus-2
(1 time)
Vascular Diseases
(1 time)
ACE-2 (1 time)
ATII (1 time)
TF (1 time)
2020 Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19.
18  sickness coronavirus 2
(1 time)
Molecular Biology
(1 time)
--- 2020 Is BCG vaccination causally related to reduced COVID-19 mortality?
19  Since December 2019, a number of patients infected with COVID-19
(1 time)
Pediatrics
(1 time)
--- 2020 Analysis and suggestions for the preview and triage screening of children with suspected COVID-19 outside the epidemic area of Hubei Province.
20  Since the outbreak of 2019 novel coronavirus
(1 time)
Virology
(1 time)
COVID-19 (1 time)
IL (1 time)
ILD (1 time)
2020 Clinical characteristics of COVID-19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, China.
21  site of infection with Coronavirus-2
(1 time)
Optometry
(1 time)
ACE2 (1 time)
COVID-19 (1 time)
2020 The ocular surface, coronaviruses and COVID-19.
22  Strategies to halt 2019 novel coronavirus
(1 time)
Transplantation
(1 time)
--- 2020 Strategies to halt 2019 novel coronavirus (SARS-CoV-2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China.
23  Study on Knowledge, Behavior, and Attitude Toward Novel Coronavirus 2019
(1 time)
Public Health
(1 time)
--- 2020 A Study on Knowledge, Behavior, and Attitude Toward Novel Coronavirus 2019 (SARS-CoV-2) Among the Jordanian Population.
24  subsequently defined as the new coronavirus of 2019
(1 time)
Medicine
(1 time)
ICU (1 time)
2020 [Intensive care during the 2019-coronavirus epidemic].
25  Subsequently, coronavirus 2
(1 time)
Medicine
(1 time)
IL (1 time)
2020 COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
26  such as the coronavirus 2
(1 time)
Environmental Health
(1 time)
--- 2020 A Systems Approach to Assess Transport and Diffusion of Hazardous Airborne Particles in a Large Surgical Suite: Potential Impacts on Viral Airborne Transmission.
27  suspected for novel Coronavirus 2019
(1 time)
Radiology
(1 time)
--- 2020 Diagnostic impact of bedside chest X-ray features of 2019 novel coronavirus in the routine admission at the emergency department: case series from Lombardy region.
28  sustained by the 2019 novel coronavirus
(1 time)
Chemistry, Clinical
(1 time)
FDP (1 time)
FIB (1 time)
PT-act (1 time)
2020 Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
29  swab for 2019-novel coronavirus
(1 time)
General Surgery
(1 time)
--- 2020 Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus (SARS-CoV-2) safely: How to dress, undress, and technical notes.
30  syndrome due to CoronaVirus-2
(1 time)
Medicine
(1 time)
RCT (1 time)
RCTs (1 time)
2020 Systematic Review on Repurposing Use of Favipiravir Against SARS-CoV-2.
31  syndrome due to the coronavirus 2
(1 time)
Medicine
(1 time)
SIAARTI (1 time)
2020 Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances.
32  syndrome pandemic caused by the novel coronavirus 2
(1 time)
--- 2020 Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents.
33  Syndrome related to Coronavirus-2
(1 time)
Allergy and Immunology
(1 time)
COVID-19 (1 time)
2020 Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.
34  syndrome-related coronavirus-2, the viral pathogen causing COVID-19 disease
(1 time)
COVID-19 (1 time)
SIR (1 time)
2020 Creating and applying SIR modified compartmental model for calculation of COVID-19 lockdown efficiency.